Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 129   

Articles published

VRX 117.53 +3.72 (3.27%)
price chart
Valeant Pharmaceuticals International Inc shares pummelled on lower 2014 ...
Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, on Thursday cut its 2014 and 2015 profit forecasts, sending shares almost 7% lower.
(PR) Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results  Wall Street Journal
Allergan Sues Valeant Claiming Insider Scheme With Ackman  Bloomberg
Related articles »  
Valeant Extends Offer To Acquire Allergan
15, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that it has extended the expiration of its exchange offer to acquire all of the outstanding shares of Allergan, Inc. ("Allergan") (NYSE: AGN) to 5:00 p.m ...
Valeant Pushes Allergan Offer Till Year End  Bidness Etc
Ackman Dangles IPO of Pershing Square Holdings in 2014  Bloomberg
Related articles »  
Allergan, Inc. (AGN) vs. Valeant Pharmaceuticals Intl Inc (VRX): Losing Ground ...
Allergan, Inc. (NYSE:AGN) approached David Carter, Federal Judge in Sana Ana California, to speed up its case and give a ruling within 120 days.
Allergen Vs Valeant: The Battle Continues  Bidness Etc
US court denies Allergan bid to speed insider trading suit  Reuters Canada
Related articles »  
Walgreen Company (WAG), llumina Inc. (ILMN), Valeant Pharmaceuticals Intl Inc ...
The $59.3 billion market cap drugstore operator saw the fund trim its stake by 17% over the second quarter; however, it kept the front-runner position, coming in very close to Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Viking Global disclosed ...
Baidu Inc (ADR) (BIDU), Cognizant Technology Solutions Corp (CTSH), Valeant ...
On third place sits Valeant Pharmaceuticals Intl Inc (NYSE:VRX), the Canadian company involved in a high profile hostile takeover of its American counterpart Allergan, Inc. (NYSE:AGN).
Pharma Stocks Review -- Eli Lilly, Zogenix, GlaxoSmithKline, Novo Nordisk, and ...
On Wednesday, shares in Valeant Pharmaceuticals International Inc. recorded a trading volume of 1.78 million shares, which was below its three months average volume of 3.30 million shares.
Related articles »  
Microsoft Corporation (MSFT), Valeant Pharmaceuticals Intl Inc (VRX), Motorola ...
On the second place there is Canadian Valeant Pharmaceuticals Intl Inc (NYSE:VRX), where Ubben holds a stake of 18 million shares, unchanged from the last quarter.
Baker Hughes Incorporated (BHI), Whiting Petroleum Corp (WLL), Valeant ...
Last in this list is Valeant Pharmaceuticals Intl Inc (NYSE:VRX), a $36.8 billion market cap specialty pharmaceutical and medical device company that saw Mr. Cohen boost his participation exponentially over the second quarter.
Related articles »  
Valeant Pharmaceuticals International Becomes Oversold (VRX)
In trading on Thursday, shares of Valeant Pharmaceuticals International Inc (Toronto: VRX) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $116.07 per share.
Related articles »  
Institutional Shareholder Services (ISS) Recommends Allergan Shareholders ...
LAVAL, Quebec and NEW YORK, Aug. 6, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX: VRX) and Pershing Square Capital Management, L.P.
War between Valeant, Perishing Square & Allergan Intensifies  Bidness Etc
Related articles »